Second shed sucks (me again xd)
    Progress Pictures 1/29/2026

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Ketoconazole →

    antifungal with some anti-androgenic benefits, often used as a shampoo

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    šŸ’Š Finasteride (oral) 1 mg daily 7 months
    šŸ’Š Minoxidil (oral) 5 mg daily 7 months
    šŸ’§ Ketoconazole (topical) twice a week 7 months
    the tone is concerned with high responder results.

    Other terms

    The user is experiencing a second hair shedding phase after 7 months on finasteride, oral minoxidil, and ketoconazole, and is concerned about the sustainability of the treatment. Others encourage continuing the treatment, explaining that shedding is normal and should stabilize over time.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Interventions for Female Pattern Hair Loss

      research Interventions for female pattern hair loss

      21 citations , May 2016 in “The Cochrane library”
      This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.
      Interventions for Female Pattern Hair Loss

      research Interventions for female pattern hair loss

      35 citations , May 2012 in “Cochrane Database of Systematic Reviews”
      This review found evidence supporting the effectiveness and safety of topical minoxidil for treating female pattern hair loss, though many included studies were at high risk of bias.
      Managing Patterned Hair Loss – A Hair Raising Task!

      research Managing patterned hair loss – a hair raising task!

      October 2021 in “Cosmoderma”
      This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.